QIAstat-Dx test kit for SARS-CoV-2 gets EUA

Create PDF

April 1, 2020—Qiagen has received emergency use authorization from the FDA for its QIAstat-Dx Respiratory SARS-CoV-2 Panel test for use in diagnosing patients infected with the novel COVID-19 coronavirus.